| Neurofilaments as biomarkers in neurological disorders M Khalil, CE Teunissen, M Otto, F Piehl, MP Sormani, T Gattringer, ... Nature Reviews Neurology 14 (10), 577-589, 2018 | 1777 | 2018 |
| Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis G Disanto, C Barro, P Benkert, Y Naegelin, S Schädelin, A Giardiello, ... Annals of neurology 81 (6), 857-870, 2017 | 1127 | 2017 |
| Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ... Nature medicine 25 (2), 277-283, 2019 | 859 | 2019 |
| Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa J Kuhle, C Barro, U Andreasson, T Derfuss, R Lindberg, Å Sandelius, ... Clinical Chemistry and Laboratory Medicine (CCLM) 54 (10), 1655-1661, 2016 | 755 | 2016 |
| Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis C Barro, P Benkert, G Disanto, C Tsagkas, M Amann, Y Naegelin, ... Brain 141 (8), 2382-2391, 2018 | 509 | 2018 |
| Blood neurofilament light chain as a biomarker of MS disease activity and treatment response J Kuhle, H Kropshofer, DA Haering, U Kundu, R Meinert, C Barro, ... Neurology 92 (10), e1007-e1015, 2019 | 505 | 2019 |
| Serum neurofilament light levels in normal aging and their association with morphologic brain changes M Khalil, L Pirpamer, E Hofer, MM Voortman, C Barro, D Leppert, ... Nature communications 11 (1), 812, 2020 | 503 | 2020 |
| Neurofilament light chain: a biomarker for genetic frontotemporal dementia LH Meeter, EG Dopper, LC Jiskoot, R Sanchez‐Valle, C Graff, L Benussi, ... Annals of clinical and translational neurology 3 (8), 623-636, 2016 | 292 | 2016 |
| Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity J Kuhle, C Barro, G Disanto, A Mathias, C Soneson, G Bonnier, Ö Yaldizli, ... Multiple Sclerosis Journal 22 (12), 1550-1559, 2016 | 291 | 2016 |
| Serum neurofilament light chain levels in patients with presymptomatic multiple sclerosis K Bjornevik, KL Munger, M Cortese, C Barro, BC Healy, DW Niebuhr, ... JAMA neurology 77 (1), 58-64, 2020 | 246 | 2020 |
| Serum neurofilament is associated with progression of brain atrophy and disability in early MS J Kuhle, B Nourbakhsh, D Grant, S Morant, C Barro, Ö Yaldizli, D Pelletier, ... Neurology 88 (9), 826-831, 2017 | 223 | 2017 |
| Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis N Siller, J Kuhle, M Muthuraman, C Barro, T Uphaus, S Groppa, L Kappos, ... Multiple Sclerosis Journal 25 (5), 678-686, 2019 | 221 | 2019 |
| Blood neurofilament light: a critical review of its application to neurologic disease C Barro, T Chitnis, HL Weiner Annals of clinical and translational neurology 7 (12), 2508-2523, 2020 | 218 | 2020 |
| Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis E Feneberg, P Oeckl, P Steinacker, F Verde, C Barro, P Van Damme, ... Neurology 90 (1), e22-e30, 2018 | 213 | 2018 |
| Serum neurofilament light: a biomarker of neuroaxonal injury after ischemic stroke S Tiedt, M Duering, C Barro, AG Kaya, J Boeck, FJ Bode, M Klein, F Dorn, ... Neurology 91 (14), e1338-e1347, 2018 | 192 | 2018 |
| Serum neurofilament light is sensitive to active cerebral small vessel disease T Gattringer, D Pinter, C Enzinger, T Seifert-Held, M Kneihsl, S Fandler, ... Neurology 89 (20), 2108-2114, 2017 | 191 | 2017 |
| Association between serum neurofilament light chain levels and long-term disease course among patients with multiple sclerosis followed up for 12 years E Cantó, C Barro, C Zhao, SJ Caillier, Z Michalak, R Bove, D Tomic, ... JAMA neurology 76 (11), 1359-1366, 2019 | 181 | 2019 |
| Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD M Watanabe, Y Nakamura, Z Michalak, N Isobe, C Barro, D Leppert, ... Neurology 93 (13), e1299-e1311, 2019 | 177 | 2019 |
| Neurofilament light chain predicts disease activity in relapsing-remitting MS KN Varhaug, C Barro, K Bjørnevik, KM Myhr, Ø Torkildsen, S Wergeland, ... Neurology: Neuroimmunology & Neuroinflammation 5 (1), e422, 2017 | 171 | 2017 |
| Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity H Högel, E Rissanen, C Barro, M Matilainen, M Nylund, J Kuhle, L Airas Multiple Sclerosis Journal 26 (2), 210-219, 2020 | 156 | 2020 |
